REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 167 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 2.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,124,000 | -20.6% | 14,000 | -6.7% | 1.40% | -8.4% |
| Q2 2019 | $1,415,000 | -33.8% | 15,000 | -40.0% | 1.53% | -27.6% |
| Q1 2019 | $2,137,000 | +52.3% | 25,000 | 0.0% | 2.11% | +20.2% |
| Q4 2018 | $1,403,000 | -28.2% | 25,000 | +4.6% | 1.76% | -15.2% |
| Q3 2018 | $1,954,000 | +39.7% | 23,900 | -40.2% | 2.07% | +46.8% |
| Q2 2018 | $1,399,000 | +13.6% | 40,000 | -33.3% | 1.41% | -4.5% |
| Q1 2018 | $1,231,000 | +8.6% | 60,000 | +50.0% | 1.48% | +3.8% |
| Q4 2017 | $1,133,000 | +21.4% | 40,000 | +33.3% | 1.42% | +45.7% |
| Q3 2017 | $933,000 | – | 30,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |